Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain

Pain

Volumn 86, Issue 3, 2000, Pages 265-271

  Levy, Dan ^a   Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bradykinin B1 receptor; Bradykinin B2 receptor; Chronic constriction injury; Dorsal root ganglia; Neuropathic pain

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; MESSENGER RNA;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LUMBAR SPINAL CORD; MALE; NONHUMAN; PAIN; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL GANGLION;

ANIMALS; BRADYKININ; CONSTRICTION, PATHOLOGIC; GANGLIA, SPINAL; HEAT; LUMBOSACRAL REGION; MALE; NERVOUS SYSTEM DISEASES; NOCICEPTORS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RNA, MESSENGER; SCIATIC NERVE; WOUNDS AND INJURIES;

EID: 0034212978     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00256-6     Document Type: Article

References (39)

1. Asbury A.K., Field H.L. Pain due to peripheral nerve damage: a hypothesis. Neurology. 34:1984;1587-1590.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Bove G.M., Light A.M. The nervi nervorum, missing link for neuropathic pain. Pain Forum. 6:1997;181-190.
4. Burgess G.M., Mullaney I., McNeill M., Dunn P.M., Rang H.P. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J Neurosci. 9:1989;3314-3325.
5. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett. 184:1995;5-8.
6. Davis C.L., Naeem S., Phagoo S.B., Campbell E.A., Urban L., Burgess G.M. B1 bradykinin receptors and sensory neurones. Br J Pharmacol. 118:1996;1469-1476.
7. Dray A., Perkins M.N. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
8. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol. 110:1993;1227-1231.
9. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
10. Khasar S.G., Miao F.J., Levine J.D. Inflammation modulates the contribution of receptor-subtypes of bradykinin-induced hyperalgesia in the rat. Neuroscience. 69:1995;685-690.
11. Koltzenburg M., Kress M., Reeh P.W. The nociceptor sensitization by bradykinin does not depend on sympathetic neurons. Neuroscience. 46:1992;465-473.
12. Koltzenburg M., Wall P.D., McMahon S.B. Does the right side know what the left is doing? Trends Neurosci. 22:1999;122-127.
13. Levy D., Zochodne D.W. Involvement of bradykinin and its B2 receptor in thermal hyperalgesia following partial peripheral nerve injury. Soc Neurosci Abstr. 23:1997;165.
14. Levy D., Zochodne D.W. Local nitric oxide activity synthase in a model of neuropathic pain. Eur J Neurosci. 10:1998;1846-1855.
15. Levy D., Hoke A., Zochodne D.W. Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett. 260:1999;207-209.
16. 125I-Tyr8] bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience. 68:1995;867-881.
17. Maves T.J., Pechman P.S., Gebhart G.F., Meller S.T. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain. 54:1993;57-69.
18. Michaelis M., Blenk K.-H., Janing W., Vogel C. Development of spontaneous activity and mechanosensitivity in axotomized afferent nerve fibers during the first hours after nerve transection in rats. J Neurophysiol. 74:1995;1020-1027.
19. Michaelis M., Vogel C., Blenk K.-H., Jaing W. Algesics excite axotomized afferent nerve fibers within the first hours following nerve transection in rats. Pain. 72:1997;347-354.
20. Michaelis M., Vogel C., Blenk K.-H., Arnarson A., Janig W. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci. 18:1998;7581-7587.
21. 8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain. 53:1993;191-197.
22. Petersen M., Eckert A.S., Segond von Banchet G., Heppelmann B., Klusch A., Kniffki K.D. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience. 83:1998;949-959.
23. Petersen M., Segond von Banchet G., Heppelmann B., Koltzenburg M. Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience. 83:1998;161-168.
24. Ramer M.S., French G.D., Bisby M.A. Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG. Pain. 72:1997;71-78.
25. Rupniak N.M., Boyce S., Webb J.K., Williams A.R., Carlson E.J., Hill R.G., Borkowski J.A., Hess J.F. Effects of the bradykinin B1 receptor antagonist des-Arg[Leu] bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain. 71:1997;89-97.
26. Seabrook G.R., Bowery B.J., Heavens R., Brown N., Ford H., Sirinathsinghi D.J., Borkowski J.A., Hess J.F., Strader C.D., Hill R.G. Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology. 36:1997;1009-1017.
27. Steranka L.R., Manning D.C., DeHaas C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M., Snyder S.H. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci USA. 85:1988;3245-3249.
28. Sufka K.J., Roach J.T. Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats. Pain. 66:1996;99-103.
29. Taiwo Y.O., Heller P.H., Levine J.D. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia. Neuroscience. 39:1990;523-531.
30. Tiffany C.W., Burch R.M. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 247:1989;189-192.
31. Wagner R., Myers R.R. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
32. Wagner R., Janjigian M., Myers R.R. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain. 74:1998;35-42.
33. Walker K., Dray A., Perkins M.N. Development of hyperthermia and hyperalgesia following intracerebroventricular administration of endotoxin in the rat: effect of kinin B1 and B2 receptor antagonists. Immunopharmacology. 33:1996;264-269.
34. Walker K., Dray A., Perkins M.N. Hyperalgesia in rats following intracerebroventricular administration of endotoxin: effect of bradykinin B1 and B2 receptor antagonist treatment. Pain. 65:1996;211-219.
35. Wong H., Anderson W.D., Cheng T., Riabowol K.T. Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping' method. Anal Biochem. 223:1994;251-258.
36. Zhou X.F., Rush R.A., McLachlan E.M. Differential expression of the p75 nerve growth factor receptor in glia and neurons of the rat dorsal root ganglia after peripheral nerve transection. J Neurosci. 16:1996;2901-2911.
37. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.
38. Zochodne D.W. Epineurial peptides: a role in neuropathic pain? Can J Neurol Sci. 20:1993;69-72.
39. Zochodne D.W., Allison J.A., Ho W., Ho L.T., Hargreaves K., Sharkey K.A. Evidence for CGRP accumulation and activity in experimental neuromas. Am J Physiol. 268:1995;H584-H590.